STOCK TITAN

Oscar Health Inc SEC Filings

OSCR NYSE

Welcome to our dedicated page for Oscar Health SEC filings (Ticker: OSCR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Oscar Health’s filings can run hundreds of pages, packed with medical loss ratio math, state-by-state premium detail, and technology capitalization rules—enough to overwhelm even seasoned analysts. If you have ever asked, “How do I find Oscar Health’s quarterly earnings report 10-Q filing?” or searched for “Oscar Health insider trading Form 4 transactions,” you know the challenge.

Stock Titan solves it. Our AI reads every 10-K, 10-Q, 8-K, and proxy the moment they post to EDGAR, then delivers plain-English explanations. Want the cash-burn trend without scanning footnotes? Need Form 4 insider transactions real-time to see when executives buy shares? Curious about how Oscar’s telehealth investment shows up in the annual report 10-K simplified? One click, instant clarity.

Here is what you can track today:

  • Revenue and membership shifts in each Oscar Health SEC filings explained simply
  • Oscar Health executive stock transactions Form 4 with real-time alerts
  • Oscar Health proxy statement executive compensation breakdowns
  • Material policy updates via Oscar Health 8-K material events explained
  • Quarterly results through the Oscar Health earnings report filing analysis

Because filings update fast, our platform refreshes the moment a document hits EDGAR, ensuring you never miss an 8-K about a new state license or a Form 4 hinting at insider confidence. Understanding Oscar Health SEC documents with AI means spending minutes, not hours, to uncover the metrics that move premiums, profitability, and your investment decisions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Oscar Health insider filings show option exercise and share sale by Mario Schlosser. Mr. Schlosser exercised 555,165 vested stock options with a $6.36 exercise price on 09/22/2025, creating the right to 555,165 Class A shares. Concurrently he converted and sold 395,000 Class A shares in multiple transactions at a weighted average price of $18.43 to cover the exercise cost and tax withholding, leaving him with 501,148 Class A shares beneficially owned. Certain remaining shares are held indirectly in family dynasty trusts over which he disclaims beneficial ownership except for any pecuniary interest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Summary

Oscar Health, Inc. (OSCR) submitted a Form 144 notice reporting a proposed sale of 395,000 common shares through Morgan Stanley Smith Barney LLC on the NYSE with an approximate aggregate market value of $7,280,995.50. The filing shows the shares were acquired and will be sold on 09/22/2025 via exercise of options under a registered plan and payment was in cash. The filer reports 223,044,000 shares outstanding for the issuer and indicates no other securities were sold in the past three months. The notice includes the standard representation that the seller is unaware of undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Oscar Health, Inc. filed an 8-K reporting execution of an Indenture dated September 18, 2025 between the company and U.S. Bank Trust Company, National Association as trustee. The filing includes the form of certificate for 2.25% Convertible Senior Subordinated Notes due 2030 (Exhibit A to Exhibit 4.1) and a form of Capped Call Confirmation. The submission also contains the cover page interactive data file embedded in the inline XBRL document. The filing is signed by R. Scott Blackley, Chief Financial Officer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Oscar Health, Inc. filed an 8-K reporting that it has given notice of its intent to terminate the revolving credit facility that is part of its senior secured credit agreement with Wells Fargo Bank, N.A. and other lenders; the termination is contingent on the closing of an offering and will occur concurrently with that closing. The company disclosed an offering of notes to qualified institutional buyers under Rule 144A, and attached a press release as Exhibit 99.1. The report is signed by R. Scott Blackley, Chief Financial Officer and dated September 16, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.27%
Tags
current report
-
Rhea-AI Summary

Oscar Health, Inc. disclosed an amendment to its January 27, 2022 Investment Agreement with Dragoneer-affiliated funds to permit an offering of securities. The filing states the company expects to terminate its revolving credit facility concurrently with the closing of the offering; that termination is contingent on the offering closing. The offering is described as a Rule 144A placement to qualified institutional buyers. A press release dated September 15, 2025 is attached as Exhibit 99.1 and the report is signed by Chief Financial Officer R. Scott Blackley.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.1%
Tags
current report
-
Rhea-AI Summary

Victoria Baltrus, identified as the issuer's Chief Accounting Officer, reported a transaction on 09/02/2025 involving Class A common stock of Oscar Health, Inc. (OSCR). The filing shows a Code F disposition on 09/02/2025 where 6,266 shares were withheld by the issuer to satisfy tax withholding at a reported price of $16.66 per share. After the transaction, Baltrus is reported to beneficially own 207,599 shares, which the filing states includes shares to be issued upon RSU vesting. The form was signed by an attorney-in-fact on 09/04/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Oscar Health insider reported a disposition of Class A common stock by Richard Scott Blackley, the company's Chief Financial Officer and director. On 09/02/2025 the filing shows 28,166 shares of Class A common stock were disposed of under transaction code F at a price of $16.66 per share. After the reported transaction, Mr. Blackley beneficially owned 1,376,169 shares. The filing explains 28,166 shares were withheld by the issuer to satisfy tax withholding on vested restricted stock units and that the post-transaction holdings include shares to be issued upon RSU vesting. The Form 4 was signed by an attorney-in-fact on 09/04/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Oscar Health (OSCR)?

The current stock price of Oscar Health (OSCR) is $20.69 as of October 14, 2025.

What is the market cap of Oscar Health (OSCR)?

The market cap of Oscar Health (OSCR) is approximately 5.3B.
Oscar Health Inc

NYSE:OSCR

OSCR Rankings

OSCR Stock Data

5.27B
212.68M
4.03%
76.77%
19.19%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
NEW YORK